05/15/2025
8:22 AM | Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form SCHEDULE 13G | |
05/15/2025
8:23 AM | Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form SCHEDULE 13G/A | |
05/15/2025
8:24 AM | Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form SCHEDULE 13G/A | |
05/14/2025
11:29 AM | JANUS HENDERSON GROUP PLC (Filed by)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form SCHEDULE 13G/A | |
04/28/2025
5:27 PM | Clyburn Frank (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
03/24/2025
3:55 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:32 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2025
4:40 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Wang Xiaolin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:40 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:41 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:42 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RVMDW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Revolution Medicines and its competitors with MarketBeat's FREE daily newsletter. |
03/19/2025
4:43 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:43 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
4:42 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025
4:14 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025
3:47 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025
3:18 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
6:02 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:03 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:00 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:01 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Wang Xiaolin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:01 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Wei Lin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:02 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:02 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
3:44 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2025
3:10 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
10:25 AM | JANUS HENDERSON GROUP PLC (Filed by)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form SCHEDULE 13G | |
01/22/2025
4:30 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
3:20 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024
3:50 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:08 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:09 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:06 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:07 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:07 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
8:35 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
7:42 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
7:01 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
6:39 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
3:57 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2024
3:18 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Collect $7k per month from Tesla’s SECRET dividend (Ad) Tesla doesn't pay a traditional dividend....
But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla…
Which could put up to $7,013 in your pocket every month… Click here to discover the new #1 way to invest in Tesla |
12/03/2024
8:37 PM | Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form FWP | |
12/02/2024
4:21 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 424B5 | |
12/02/2024
6:30 AM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
3:20 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
9:52 AM | Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/06/2024
4:07 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
3:05 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:10 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024
3:42 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:42 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:43 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:30 PM | Patel Sushil (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
5:43 AM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2024
5:05 AM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
3:07 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:29 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:30 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:30 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:31 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:03 AM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024
3:16 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:23 PM | Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
Weber Barbara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
3:33 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:33 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:16 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:17 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:17 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:18 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:18 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
6:06 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
5:41 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
5:22 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:37 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:15 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:24 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
3:23 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
3:15 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:48 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:34 PM | Clyburn Frank (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2024
4:34 PM | Clyburn Frank (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:07 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 424B5 | |
08/02/2024
4:35 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:29 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
4:05 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
3:27 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
7:03 AM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
3:35 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
3:36 PM | Patel Sushil (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Midnight trade alert: After-hours spike incoming??? (Ad) Most traders don’t realize this…
But the closing bell means jack $#!&.
They hear the bell and they think “time to go”...
But when Tim Sykes hears the bell? When the next closing bell rings… MAKE THIS TRADE! |
07/10/2024
3:36 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:19 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
3:19 PM | Patel Sushil (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
4:05 PM | Horning Sandra (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024
4:06 PM | Patel Sushil (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024
4:06 PM | Borisy Alexis (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024
4:07 PM | Kim Lorence H. (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024
4:07 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Weber Barbara (Reporting)
| Form 4/A | |
06/28/2024
4:08 PM | Borellini Flavia (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
